Patents Assigned to SmithKline Beecham Corporation and Ligand Pharmaceuticals
  • Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metal
    Publication number: 20030013697
    Abstract: Invented are metal chelated dimeric cell-surface receptor ligands, pharmaceutical compositions containing these compounds, and methods of using these compounds as agonist of dimeric cell-surface receptors. Also invented are novel processes used in preparing these compounds. Also invented are novel receptor binding moieties of the invented metal chelated cell-surface receptor ligands.
    Type: Application
    Filed: August 12, 2002
    Publication date: January 16, 2003
    Applicant: SmithKline Beecham Corporation and Ligand Pharmaceuticals
    Inventors: Juan I. Luengo, Stephen G. Miller, John G. Gleason